Key facts
- Omeza’s last known valuation is $1.5M (Jan 2025).
- It has raised $40.4M; the latest was Later Stage VC ($910K) in Jan 2025.
- Notable investors include Florida Opportunity Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Omeza
- ·The full record, as it builds
Funding rounds
No funding rounds for Omeza are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Omeza
Operator of a skin healthcare company intended to focus on healing chronic wounds and preventing their recurrence. The company develops omega-three oils scientifically designed to be applied topically to soothe inflamed and irritated skin, also its natural anti-inflammatory properties help enhance skin strength and elasticity, enabling patients to get access to topical omegas for healthy and happy skin.
- Sector
- Healthcare
- HQ
- Sarasota, FL, United States
- Founded
- 2014
- Employees
- 16
- Website
- omeza.com/
- Ownership
- Privately Held (backing)
Omeza doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Omeza shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Omeza in its N-PORT filings yet. We sweep new filings monthly.